October 3, 2014 / 12:22 PM / in 3 years

US STOCKS-Salix jumps after terminated merger deal, upgrade

NEW YORK, Oct 3 (Reuters) - Shares of Salix Pharmaceuticals Ltd were higher in premarket trading on Friday, up 3.2 percent to $156 in heavy volume.

The move came after the company said it had terminated a merger agreement with Swiss-listed Cosmo Pharmaceuticals SpA , citing a “changed political environment” related to “inversions,” where a company reincorporates abroad in order to escape U.S. taxes.

Separately, Credit Suisse upgraded the stock to “neutral” from “underperform” and raised its price target to $155 from $139.

Salix has been a strong performer this year, up about 68 percent in 2014.

Futures snapshot at 0814 EDT:

* S&P 500 e-minis were up 12 points, or 0.62 percent, with 150,451 contracts changing hands.

* Nasdaq 100 e-minis were up 22 points, or 0.55 percent, in volume of 22,800 contracts.

* Dow e-minis were up 89 points, or 0.53 percent, with 20,886 contracts changing hands. (Editing by Bernadette Baum)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below